ℹ️ Compiled from public regulatory records · Last regulator revision: December 17, 2025🚩 Report this page
Claviceps Purpurea Sclerotium
Active ingredient
Sold as Menopause HP · Arnicare Leg Cramps
US FDA
- Drug class
- -
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 2
- FDA reports (12 mo)
- 27
Overview
Claviceps Purpurea Sclerotium is an active pharmaceutical ingredient. The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 2 | December 17, 2025 |
USUnited States· FDA
2 products
Uses
** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
How to take
Sources & citations
- [1]FDA DailyMed · 0f0aea3f-95d2-4a… · revised December 17, 2025 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.